CN103316263A - Medicine composition for treating membranous dysmenorrhea - Google Patents
Medicine composition for treating membranous dysmenorrhea Download PDFInfo
- Publication number
- CN103316263A CN103316263A CN2013102748667A CN201310274866A CN103316263A CN 103316263 A CN103316263 A CN 103316263A CN 2013102748667 A CN2013102748667 A CN 2013102748667A CN 201310274866 A CN201310274866 A CN 201310274866A CN 103316263 A CN103316263 A CN 103316263A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composition for treating membranous dysmenorrheal. The medicine composition is prepared from the following substances: semen celosiae, radix scrophulariae, pterocephalus hookeri, herba polygoni perfoliati, common bombax flower, lophatherum gracile, thlaspi arvense, fructus arctii, liquorice, smilax, honeysuckle, herba gendarussae, American ginseng, rhizoma dioscoreae septemlobae, radix rehmanniae, caulis mahoniae, retinervus luffae fructus, herba asari, folium sauropi, scutellaria baicalensis, ricepaper pith, radix paeoniae rubra, herba siegesbeckiae, white hyacinth bean, Chinese angelica, folium sennae, lychee seed, concha arcae, herba agrimoniae, peucedanum decursivum, poria cocos, fructus broussonetiae, cassia twig, cicada slough, peach kernel, pinellia ternata, frankincense, kelp, herba cichorii, manchurian lilac bark, rhizoma nelumbinis and piper cubeba. The medicine composition for treating membranous dysmenorrheal provided by the invention has the characteristics of low cost, easiness in preparation, little toxic and side effects and obvious curative effect.
Description
Technical field
The present invention relates to drug world, specifically, relate to a kind of pharmaceutical composition for the treatment of film sample dysmenorrhea.
Background technology
Film sample dysmenorrhea is the appellation of the special dysmenorrhea of a class, refer to that menstrual phase (generally menstrual phase 2-3 days) lower abdomen has an intense pain, discharge the class primary dysmenorrhea that the rear pain of mashed meat sample of blood piece (being the endometrium flaking) is alleviated gradually, also claim " demoulding dysmenorrhea ".Mostly occur after menophania in the 2-3, the state of an illness increases progressively gradually with the age and increases the weight of.This disease is different from general dysmenorrhea, loses Zhi Yanzhi, can bring out serious premenstrual tension syndrome, secondary organic dysmenorrhea, sterility and infertility etc.At present the same primary dysmenorrhea of western medical treatment method namely uses PGSI menstrual period, or oral contraceptive etc. at ordinary times, and it is satisfied that curative effect is owed, and easily recurrence can not improve reproductive function.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of film sample dysmenorrhea.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of film sample dysmenorrhea, it is made by the material of following weight proportioning: 23 parts of Semen Celosiae, 25 parts of Radix Scrophulariaes, 33 parts of Herba pterocephali, 35 parts of Herba Polygoni cymosis, 34 parts of Flos Bombacis Malabaricis, 26 parts of 32 parts of Herba Thlaspiss of Herba Lophatheri, 18 parts of Fructus Arctiis, 24 parts in Radix Glycyrrhizae, 25 parts of Rhizoma Smilacis Chinensiss, 36 parts of Flos Loniceraes, 23 parts of Herba Gendarussaes, 24 parts of 21 parts of Rhizoma Dioscoreae Septemlobaes of Radix Panacis Quinquefolii, 28 parts in the Radix Rehmanniae, 33 parts of Caulis Mahoniaes, 23 parts of Retinervus Luffae Fructuss, 36 parts of Herba Asaris, 36 parts of Folium Sauropis, 30 parts of Radix Scutellariaes, 37 parts of Medulla Stachyuri (Medulla Helwingiae)s, 26 parts of 28 parts of Herba Siegesbeckiaes of Radix Paeoniae Rubra, 37 parts of Semen Lablab Albums, 29 parts of Radix Angelicae Sinensis, 33 parts of Folium Sennae, 27 parts of Semen Litchis, 25 parts of Concha Arcaes, 34 parts of Herba Agrimoniaes, 23 parts of RADIX PEUCEDANI, 27 parts in Poria, 25 parts of Fructus Broussonetiaes, 21 parts of Ramulus Cinnamomi, 20 parts of Periostracum Cicadaes, 28 parts in Semen Persicae, 23 parts of the Rhizoma Pinelliaes, 25 parts of Olibanums, 27 parts of Thallus Laminariae (Thallus Eckloniae)s, 37 parts of Herba Cichoriis, 35 parts of Cortex Syingae Amurensiss, 35 parts of 33 parts of Nodus Nelumbinis Rhizomatis and Fructus Litseae.
Preferably, described pharmaceutical composition can be tablet, dispersible tablet, powder or decoction.
The pharmaceutical composition for the treatment of film sample dysmenorrhea of the present invention has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
The specific embodiment
Embodiment 1:
Take by weighing Semen Celosiae 23 grams, Radix Scrophulariae 25 grams, Herba pterocephali 33 grams, Herba Polygoni cymosi 35 grams, Flos Bombacis Malabarici 34 grams, Herba Lophatheri 32 gram Herba Thlaspiss 26 grams, Fructus Arctii 18 grams, Radix Glycyrrhizae 24 grams, Rhizoma Smilacis Chinensis 25 grams, Flos Lonicerae 36 grams, Herba Gendarussae 23 grams, Radix Panacis Quinquefolii 21 gram Rhizoma Dioscoreae Septemlobaes 24 grams, the Radix Rehmanniae 28 grams, Caulis Mahoniae 33 grams, Retinervus Luffae Fructus 23 grams, Herba Asari 36 grams, Folium Sauropi 36 grams, Radix Scutellariae 30 grams, Medulla Stachyuri (Medulla Helwingiae) 37 grams, Radix Paeoniae Rubra 28 gram Herba Siegesbeckiaes 26 grams, Semen Lablab Album 37 grams, Radix Angelicae Sinensis 29 grams, Folium Sennae 33 grams, Semen Litchi 27 grams, Concha Arcae 25 grams, Herba Agrimoniae 34 grams, RADIX PEUCEDANI 23 grams, Poria 27 grams, Fructus Broussonetiae 25 grams, Ramulus Cinnamomi 21 grams, Periostracum Cicadae 20 grams, Semen Persicae 28 grams, the Rhizoma Pinelliae 23 grams, Olibanum 25 grams, Thallus Laminariae (Thallus Eckloniae) 27 grams, Herba Cichorii 37 grams, Cortex Syingae Amurensis 35 grams, Nodus Nelumbinis Rhizomatis 33 grams and Fructus Litseae 35 grams, add 8000 ml waters, 80 ℃ of lower heating 5 hours, filter.Filtrate is concentrated into 800 milliliters, namely gets decoction of the present invention.
Experimental example
1.1 diagnostic criteria
Western medicine diagnose canonical reference " obstetrics and gynecology " (Feng Youji, the Shen clang. obstetrics and gynecology, Beijing: the People's Health Publisher, 2010:249) work out: (1) has periodicity lower abdomen in menstrual period pendant pain, endometrium comes off in a tubular form, and continuous 3 menstrual cycle can not spontaneous remission; (2) gynecologial examination and ultrasound diagnosis prompting uterus adnexa no abnormality seen; (3) examination of basal body temperature confirms that dysmenorrhea occurs in ovulatory cycle.Tcm diagnosis canonical reference " Gynecology of Chinese Medicine " (Zhang Yuzhen. Gynecology of Chinese Medicine. Beijing: China Traditional Chinese Medicine Publishing House, 2007:61) dialectical main points: abdominal pain during menstruation, pain was acute in 2-3 days, and purplish red have a large amount of clots, each discharge mashed meat sample of blood piece after pain can extenuate, companion's aversion to cold and cold limbs, the stool pool is thin, or sterility, or habitual abortion, purplish tongue gas thin fur or thin greasy, deep and stringy pulse etc.
1.2 inclusive criteria
(1) meets the diagnostic criteria of film sample dysmenorrhea; (2) age is at 16-36 between year; (3) course of disease is more than March.
Choose female patient 60 examples that meet above-mentioned standard, unmarried 37 examples, married 23 examples; Year mean age (23.0 ± 4.7); Individual month of average course of disease (24.0 ± 3.9).
Decoction with preparation among the embodiment 1 is treated.Each oral 50 milliliters, respectively take 1 time every day sooner or later, treated continuously 1 month.
The efficacy determination method
Reference " traditional Chinese medical science disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect. Nanjing: the curative effect determinate standard of dysmenorrhea is formulated the .1994.61 of publishing house of Nanjing University).Clinical cure: the rear stomachache of taking medicine and mashed meat sample of blood piece disappear, and 3 menstrual cycle of drug withdrawal do not recur, and pain degree recovers " 0 " minute person; Produce effects: pain obviously alleviates, and the meat sample of blood piece that rots disappears or alleviates, and the disobedience analgesic can be adhered to work, below 1/2 of integration before pain degree is treated for the treatment integration is reduced to; Effectively: stomachache alleviates, and mashed meat sample of blood piece minimizing takes analgesic and can adhere to work, and pain degree is reduced to front below 1/3 of integration for the treatment of for integration after treating; Invalid: stomachache and mashed meat sample of blood piece are without the changer.
Through treatment, take medicine rear stomachache and mashed meat sample of blood piece of 60 routine patients disappears, and 3 menstrual cycle of drug withdrawal do not recur, and pain degree recovers " 0 " minute, therefore all meets the standard of clinical cure.
Claims (2)
1. pharmaceutical composition for the treatment of film sample dysmenorrhea is characterized in that it is made by the material of following weight proportioning: 23 parts of Semen Celosiae, 25 parts of Radix Scrophulariaes, 33 parts of Herba pterocephali, 35 parts of Herba Polygoni cymosis, 34 parts of Flos Bombacis Malabaricis, 26 parts of 32 parts of Herba Thlaspiss of Herba Lophatheri, 18 parts of Fructus Arctiis, 24 parts in Radix Glycyrrhizae, 25 parts of Rhizoma Smilacis Chinensiss, 36 parts of Flos Loniceraes, 23 parts of Herba Gendarussaes, 24 parts of 21 parts of Rhizoma Dioscoreae Septemlobaes of Radix Panacis Quinquefolii, 28 parts in the Radix Rehmanniae, 33 parts of Caulis Mahoniaes, 23 parts of Retinervus Luffae Fructuss, 36 parts of Herba Asaris, 36 parts of Folium Sauropis, 30 parts of Radix Scutellariaes, 37 parts of Medulla Stachyuri (Medulla Helwingiae)s, 26 parts of 28 parts of Herba Siegesbeckiaes of Radix Paeoniae Rubra, 37 parts of Semen Lablab Albums, 29 parts of Radix Angelicae Sinensis, 33 parts of Folium Sennae, 27 parts of Semen Litchis, 25 parts of Concha Arcaes, 34 parts of Herba Agrimoniaes, 23 parts of RADIX PEUCEDANI, 27 parts in Poria, 25 parts of Fructus Broussonetiaes, 21 parts of Ramulus Cinnamomi, 20 parts of Periostracum Cicadaes, 28 parts in Semen Persicae, 23 parts of the Rhizoma Pinelliaes, 25 parts of Olibanums, 27 parts of Thallus Laminariae (Thallus Eckloniae)s, 37 parts of Herba Cichoriis, 35 parts of Cortex Syingae Amurensiss, 35 parts of 33 parts of Nodus Nelumbinis Rhizomatis and Fructus Litseae.
2. the pharmaceutical composition for the treatment of film sample dysmenorrhea according to claim 1 is characterized in that, described pharmaceutical composition can be tablet, dispersible tablet, powder or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310274866.7A CN103316263B (en) | 2013-07-03 | 2013-07-03 | Medicine composition for treating membranous dysmenorrhea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310274866.7A CN103316263B (en) | 2013-07-03 | 2013-07-03 | Medicine composition for treating membranous dysmenorrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103316263A true CN103316263A (en) | 2013-09-25 |
| CN103316263B CN103316263B (en) | 2014-07-30 |
Family
ID=49185496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310274866.7A Expired - Fee Related CN103316263B (en) | 2013-07-03 | 2013-07-03 | Medicine composition for treating membranous dysmenorrhea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103316263B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095930A (en) * | 2007-07-12 | 2008-01-02 | 张琴 | Olibanum zedoary plaster for treating menorrhalgia and the preparation technics thereof |
| CN101129902A (en) * | 2007-08-31 | 2008-02-27 | 南京中医药大学 | Application of disease-eliminating drink in preparing medicine for treating menorrhalgia and uterine gland myopathia |
| CN101264314A (en) * | 2008-05-04 | 2008-09-17 | 北京中科仁和科技有限公司 | Medicaments assembly for clearing heat and detoxication, activating blood circulation and removing stasis, and diminishing inflammation and reducing pain |
-
2013
- 2013-07-03 CN CN201310274866.7A patent/CN103316263B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095930A (en) * | 2007-07-12 | 2008-01-02 | 张琴 | Olibanum zedoary plaster for treating menorrhalgia and the preparation technics thereof |
| CN101129902A (en) * | 2007-08-31 | 2008-02-27 | 南京中医药大学 | Application of disease-eliminating drink in preparing medicine for treating menorrhalgia and uterine gland myopathia |
| CN101264314A (en) * | 2008-05-04 | 2008-09-17 | 北京中科仁和科技有限公司 | Medicaments assembly for clearing heat and detoxication, activating blood circulation and removing stasis, and diminishing inflammation and reducing pain |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103316263B (en) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725A (en) | Traditional Chinese medicine compound preparation for treating chronic pelvic inflammation and preparation method thereof | |
| CN102488879B (en) | Medicinal composition for treating rheumatism | |
| CN101912593A (en) | Medicament for treating dysmenorrheal and preparation method thereof | |
| CN103919940A (en) | Chinese medicinal composition for treating hemorrhoid | |
| CN102008584B (en) | Drug for treating cold-aggregating qi-stasis dysmenorrhea | |
| CN102284050B (en) | Chinese medicine composition for treating infertility caused by cold uterus | |
| CN103800843A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN104435519A (en) | Pharmaceutical composition for treating primary dysmenorrhea | |
| CN101797325B (en) | Medicament composition for treating gynecologic inflammation and preparation method and application thereof | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN103860882A (en) | Medicinal preparation for treating chronic cervicitis | |
| CN102091296B (en) | Medicament for treating breast hyperplasia | |
| CN103316263B (en) | Medicine composition for treating membranous dysmenorrhea | |
| CN103463582A (en) | Medicinal composition for treating pelvic inflammation, as well as preparation and application thereof | |
| CN104013704B (en) | Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN103330897B (en) | Pharmaceutical composition for treating renal and ureteral calculus | |
| CN103550668B (en) | A kind of Chinese medicine for the treatment of gynecological's habitual abortion disease | |
| CN105250519A (en) | Traditional Chinese medicine composition for relieving sequelae of pelvic inflammatory disease and application of traditional Chinese medicine composition | |
| CN104644956A (en) | Traditional Chinese medicine composition for treating cold congealing and blood stasis type dysmenorrheal and preparation method thereof | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103301415A (en) | Medicinal composition for preventing and treating intrauterine adhesion after induced abortion operation and application thereof | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN102526373B (en) | Medicinal composition for treating infantile anorexia | |
| CN105920539A (en) | Medicament for treating foot-and-mouth disease of sheep |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI YANNAN Free format text: FORMER OWNER: LI HUA Effective date: 20140702 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Yannan Inventor before: Li Hua |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 272000 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI HUA TO: LI YANNAN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140702 Address after: Chinese Medicine Hospital No. 3 Jining City Road 272000 in Shandong Province, Jining City Applicant after: Li Yannan Address before: Building 100083 Beijing city Haidian District Yihai Qinghua East Road, Room 608 Applicant before: Li Hua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140730 Termination date: 20150703 |
|
| EXPY | Termination of patent right or utility model |